Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients

Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients

Introduction: Bronchial asthma is a common chronic inflammatory airway disease diagnosed and is based on symptomatic history and Pulmonary Function Tests (PFT). Fractional exhaled Nitric Oxide (FeNO) is exclusively a noninvasive biomarker of on-going eosinophilic airway inflammation which remain...

Full description

Bibliographic Details
Main Authors: Revathy Neelamegan, Vinodkumar Saka, Kadhiravan Tamilarasu, Manju Rajaram, Sandhiya Selvarajan, Adithan Chandrasekaran
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-12-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
bronchial asthma
mild-to-moderate persistent asthma
tamilian
Online Access:https://jcdr.net/articles/PDF/8950/20656_CE(Ra1)_F(AK)_PF1(PJ)_PFA(AK)_PF2(PAG).pdf

Internet

https://jcdr.net/articles/PDF/8950/20656_CE(Ra1)_F(AK)_PF1(PJ)_PFA(AK)_PF2(PAG).pdf

Similar Items